Related references
Note: Only part of the references are listed.Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [C-11] NNC112 and [C-11] raclopride
Mark Slifstein et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Imaging dopamine receptors in humans with [C-11]-(+)-PHNO: Dissection of D3 signal and anatomy
Andri C. Tziortzi et al.
NEUROIMAGE (2011)
The Synthesis and Preclinical Evaluation in Rhesus Monkey of [18F]MK-6577 and [11C]CMPyPB Glycine Transporter 1 Positron Emission Tomography Radiotracers
Terence G. Hamill et al.
SYNAPSE (2011)
Adaptive-Optimal Design in PET Occupancy Studies
S. Zamuner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited
Vincent J. Cunningham et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Identification and Evaluation of [11C]GSK931145 as a Novel Ligand for Imaging the Type 1 Glycine Transporter With Positron Emission Tomography
J. Passchier et al.
SYNAPSE (2010)
A Biomathematical Modeling Approach to Central Nervous System Radioligand Discovery and Development
Qi Guo et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Positron Emission Tomography Imaging of D2/3 Agonist Binding in Healthy Human Subjects With the Radiotracer [11C]-N-Propyl-Norapomorphine: Preliminary Evaluation and Reproducibility Studies
Rajesh Narendran et al.
SYNAPSE (2009)
Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457:: re-evaluation of the validity of using a cerebellar reference region
Marie-Claude Asselin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain
SG Summerfield et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia - A randomized, double-blind, placebo-controlled study
HY Lane et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Glycine transporters:: crucial roles of pharmacological interest revealed by gene deletion
C Aragón et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain
B Cubelos et al.
CEREBRAL CORTEX (2005)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
GC Tsai et al.
BIOLOGICAL PSYCHIATRY (2004)
Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol
BT Christian et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET
H Olsson et al.
NEUROIMAGE (2004)
Imaging human mesolimbic dopamine transmission with positron emission tomography:: I.: Accuracy and precision of D2 receptor parameter measurements in ventral striatum
O Mawlawi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans:: Comparison of arterial and reference tissue input functions
RV Parsey et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans:: Validation and reproducibility
A Abi-Dargham et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Share Paper
